ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: A rationale for safer glucocorticoid replacement therapy
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Corticosterone is as effective as cortisol for ACTH suppression but lacks metabolic adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Differential tissue expression of the glucocorticoid transmembrane transporters has led to the consideration of corticosterone as an alternative therapeutic option in treating CAH, with potentially decreased effects on peripheral tissues and enhanced influence on the HPA axis117.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation
Wabitsch, M., Brenner, R., Melzner, I., Braun, M., Möller, P., Heinze, E., Debatin, K.-M., & Hauner, H. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801520 · Cited by 562
Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., Valk, M. V. D., Krimpenfort, P., & Borst, P. (1997) · Nature Medicine · doi:10.1038/nm1197-1275 · Cited by 432
Gekeler, V., Ise, W., Sanders, K. H., Ulrich, W. R., & Beck, J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1344 · Cited by 396
Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0054 · Cited by 385
Self-citationUltradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription
Stavreva, D. A., Wiench, M., John, S., Conway-Campbell, B. L., McKenna, M. A., Pooley, J. R., Johnson, T. A., Voss, T. C., Lightman, S. L., & Hager, G. L. (2009) · Nature Cell Biology · doi:10.1038/ncb1922 · Cited by 375
Meijer, O. C. (1998) · Endocrinology · doi:10.1210/en.139.4.1789 · Cited by 375
Karssen, A. M. (2001) · Endocrinology · doi:10.1210/en.142.6.2686 · Cited by 280
Research works printed but not linked: 2
- 10.1210/endo.139.4.5917 · doi:10.1210/endo.139.4.5917 · Paper page
- 10.1210/endo.142.6.8213 · doi:10.1210/endo.142.6.8213 · Paper page
Cited by
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
The cortisol switch between vulnerability and resilience
de Kloet, E. R., & Joëls, M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01934-8 · Cited by 174
“In rodents two Abcb1 isoforms – Abcb1a and Abcb1b-exist, the former being the one abundantly expressed in the blood-brain barrier [225, 226].”
Meakin, A. S., Cuffe, J. S. M., Darby, J. R. T., Morrison, J. L., & Clifton, V. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126386 · Cited by 158
“[64] reported increased mRNA expression of Abcb1a in female placentae in response to stress.”
BackgroundVARIDT 1.0: variability of drug transporter database
Yin, J., Sun, W. C., Li, F., Hong, J., Li, X., Zhou, Y., Lu, Y., Liu, M., Zhang, X. Z., Chen, N., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz779 · Cited by 141
“There are three aspects of variability: (a) epigenetic regulation and genetic polymorphism of DT that are key in drug resistance (5) and clinical treatment optimization (6); (b) species, tissue- and disease-specific DT abundances that are vital in bridging preclinical study with clinical trial (7), balancing efficacy…”
BackgroundManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
High-resolution daily profiles of tissue adrenal steroids by portable automated collection
Upton, T. J., Zavala, E., Methlie, P., Kämpe, O., Tsagarakis, S., Øksnes, M., Bensing, S., Vassiliadi, D. A., Grytaas, M. A., Botusan, I. R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg8464 · Cited by 94
“Recent data have suggested that this hormone may have distinct tissue-specific glucocorticoid effects in humans, related to its ABCC1 transporter affinity for which ACTH dependence would seem appropriate (37).”
BackgroundDrugMAP: molecular atlas and pharma-information of all drugs
Li, F., Yin, J., Lu, M., Mou, M., Li, Z., Zeng, Z., Tan, Y. C., Wang, S., Chu, X., Dai, H., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac813 · Cited by 93
VARIDT 2.0: structural variability of drug transporter
Fu, T., Li, F., Zhang, Y., Yin, J., Qiu, W., Li, X., Liu, X., Xin, W., Wang, C., Yu, L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1013 · Cited by 90
VARIDT 1.0: variability of drug transporter database
Yin, J., Sun, W. C., Li, F., Hong, J., Li, X., Zhou, Y., Lu, Y., Liu, M., Zhang, X. Z., Chen, N., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz878 · Cited by 77
“There are three aspects of variability: (a) epigenetic regulation and genetic polymorphism of DT that are key in drug resistance (5) and clinical treatment optimization (6); (b) species, tissue- and disease-specific DT abundances that are vital in bridging preclinical study with clinical trial (7), balancing efficacy…”
BackgroundDRESIS: the first comprehensive landscape of drug resistance information
Sun, X., Zhang, Y., Li, H., Zhou, Y., Shi, S., Chen, Z., He, X., Zhang, H., Li, F., Yin, J., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac812 · Cited by 82
Sex-specific regulation of stress-induced fetal glucocorticoid surge by the mouse placenta
Wieczorek, A., Perani, C. V., Nixon, M., Constancia, M., Sandovici, I., Zazara, D. E., Leone, G., Zhang, M.-Z., Arck, P. C., & Solano, M. E. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00551.2018 · Cited by 61
Self-citationSeal, S. V., & Turner, J. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073344 · Cited by 69
“The two molecules are differentially shuttled across membranes in humans by ATP binding cassettes (ABC), resulting in differential responses to them in a tissue specific manner [30].”
BackgroundBrain mineralocorticoid receptor function in control of salt balance and stress-adaptation
de Kloet, E. R., & Joëls, M. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.12.045 · Cited by 59
Hunt, K. E., Lysiak, N. S. J., Moore, M. J., & Rolland, R. M. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.09.009 · Cited by 47
“The two hormones have differing affinities for corticosteroid binding globulin, transporters and receptors (Funder, 2013; MacKenzie, 2015; Nixon et al., 2016; Sacta et al., 2016).”
BackgroundThe Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk
Di Dalmazi, G., Fanelli, F., Zavatta, G., Ricci Bitti, S., Mezzullo, M., Repaci, A., Pelusi, C., Gambineri, A., Altieri, P., Mosconi, C., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00365 · Cited by 42
Johns, E. C., Denison, F. C., & Reynolds, R. M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.025 · Cited by 48
“ABCC1 exports corticosterone (not cortisol) and is predominantly localised on the fetal facing BM [49,50].”
BackgroundSelf-citationThe ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action
Devine, K., Villalobos, E., Kyle, C. J., Andrew, R., Reynolds, R. M., Stimson, R. H., Nixon, M., & Walker, B. R. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00745-9 · Cited by 44
Self-citationVARIDT 3.0: the phenotypic and regulatory variability of drug transporter
Yin, J., Chen, Z., You, N., Li, F., Zhang, H., Jia, X., Ma, H., Zhao, Q. D., Yu, L., Zeng, S., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad818 · Cited by 33
“…clinical treatment optimization ( 9 ,78 ), and is essential for bridging preclinical study with clinical trial ( 79 ), balancing efficacy & safety ( 80–82 ), and predicting disease-drug interaction ( 83–85 ), and DT-related variability data can lay the foundation for big data-driven precision…”
BackgroundGlucocorticoids are lower at delivery in maternal, but not cord blood of obese pregnancies
Stirrat, L., Just, G., Homer, N. Z. M., Andrew, R., Norman, J. E., & Reynolds, R. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-10266-5 · Cited by 35
Self-citationPulsatility of glucocorticoid hormones in pregnancy: Changes with gestation and obesity
Stirrat, L., Walker, J. J., Stryjakowska, K., Jones, N. K., Homer, N. Z. M., Andrew, R., Norman, J. E., Lightman, S. L., & Reynolds, R. M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13548 · Cited by 32
Self-citationDysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction
Morgan, R., Keen, J., Homer, N. Z. M., Nixon, M., McKinnon-Garvin, A. M., Moses-Williams, J. A., Davis, S. R., Hadoke, P. W. F., & Walker, B. R. (2018) · Endocrinology · doi:10.1210/en.2018-00726 · Cited by 30
Self-citationThe selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity
Koorneef, L. L., Kroon, J., Viho, E. M. G., Wahl, L. F., Heckmans, K. M. L., van Dorst, M. M. A. R., Hoekstra, M., Houtman, R., Hunt, H., & Meijer, O. C. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0486 · Cited by 31
Residual endogenous corticosteroid production in patients with adrenal insufficiency
Vulto, A., Bergthorsdottir, R., van Faassen, M. H. J. R., Kema, I. P., Johannsson, G., & van Beek, A. P. (2019) · Clinical Endocrinology · doi:10.1111/cen.14006 · Cited by 25
Melvin, A., Chantzichristos, D., Kyle, C. J., Mackenzie, S. D., Walker, B. R., Johannsson, G., Stimson, R. H., & O’Rahilly, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz277 · Cited by 26
“Cohort 2: Addison’s disease Full details of this protocol have been published previously (33).”
BackgroundMethodSelf-citationLuo, J., Luo, J., Wu, Y., Fu, Y., Fang, Z., Han, B., Du, B., Yang, Z., & Xu, B. (2024) · Antioxidants · doi:10.3390/antiox13111380 · Cited by 22
Effects of Obesity and Insulin on Tissue-Specific Recycling Between Cortisol and Cortisone in Men
Anderson, A. J., Andrew, R., Homer, N. Z. M., Hughes, K. A., Boyle, L. D., Nixon, M., Karpe, F., Stimson, R. H., & Walker, B. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa896 · Cited by 19
“Quantitative polymerase chain reaction was performed as described previously (33) in a subset of adipose biopsies, where sufficient quantities of paired samples were obtained (lean n = 7, obese n = 6).”
MethodSelf-citationKyle, C. J., Nixon, M., Homer, N. Z. M., Morgan, R., Andrew, R., Stimson, R. H., & Walker, B. R. (2022) · Metabolism · doi:10.1016/j.metabol.2021.155118 · Cited by 16
“This interpretation might be considered to be at odds with our previous results showing that cortisol and corticosterone are equally potent at suppressing ACTH during infusion in patients with Addison's disease [13].”
BackgroundMethodResultSelf-citationBell, R. M. B., Villalobos, E., Nixon, M., Miguelez-Crespo, A., Murphy, L., Fawkes, A., Coutts, A. A., Sharp, M. G. F., Koerner, M. V., Allan, E., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101225 · Cited by 16
“RNA sequencing analysis of adipose tissue C57BL/6J male mice (8 weeks of age, n 1⁄4 6/group) underwent adrenalectomy to remove endogenous steroids as previously described [32].”
Self-citationThe NE/AAT/CBG axis regulates adipose tissue glucocorticoid exposure
Boyle, L. D., Miguelez-Crespo, A., Paul, M. A., Villalobos, E., Toews, J. N. C., Ivatt, L., Nagy, B. R., Magennis, M., Homer, N. Z. M., Andrew, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55693-x · Cited by 11
Self-citationThe importance of the circadian trough in glucocorticoid signaling: a variation on B-flat
Meijer, O. C., Kooijman, S., Kroon, J., & Winter, E. M. (2023) · Stress · doi:10.1080/10253890.2023.2275210 · Cited by 11
“…F is transported out of adipocytes through ABcc1, and this has been used as an argument for the use of B rather than F in human hormone replacement (Nixon et al., 2016). in this review, we will focus on the importance of one particular aspect of Gc control, namely the importance of a daily trough…”
MethodWhy not both? A case study in measuring cortisol and corticosterone
Westrick, S. E., Paitz, R. T., & Fischer, E. K. (2025) · Integrative Organismal Biology · doi:10.1093/iob/obaf041 · Cited by 9
Thyroid Hormones, Glucocorticoids, Insulin, and Bone
Lakatos, P. L., Szili, B., Bakos, B., Takács, I., Putz, Z., & Istenes, I. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_314 · Cited by 9
Romanò, N., Duncan, P., McClafferty, H., Nolan, O., Ding, Q., Homer, N., Tissier, P. L., Walker, B., Shipston, M., & Chambers, T. J. G. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13165 · Cited by 9
“Quantitative analysis of the extracts was carried out on a Nexera UHPLC – Sciex QTrap 6500+ LC-MS/MS instrument, operated in positive ion mode, as described previously.(19,20) For Experiment 2, a low volume extraction method was developed for mouse plasma and combined with an LC-MS/MS method adapted froma previous stu…”
MethodSelf-citationYu, J. Q., Xie, X., Zhang, Y., Jiang, F., & Wu, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.906001 · Cited by 11
“ABCC1 mRNA is increased in adult adipose tissue, while tissue plasma cortisol concentrations are continuously low (14, 15).”
BackgroundWang, N., Ockerman, F. P., Zhou, L. Y., Grove, M. L., Alkis, T., Barnard, J., Bowler, R. P., Clish, C. B., Chung, S., Drzymalla, E., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.08.022 · Cited by 10
Contribution of local regeneration of glucocorticoids to tissue steroid pools
Khan, S., Livingstone, D. E. W., Zielinska, A. E., Doig, C. L., Cobice, D., Esteves, C. L., Man, J. T. Y., Homer, N. Z. M., Seckl, J. R., Mackay, C. L., et al. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0034 · Cited by 6
Self-citationRole of Hepatic Glucocorticoid Receptor in Metabolism in Models of 5αR1 Deficiency in Male Mice
Mak, T. C. S., Livingstone, D. E. W., Nixon, M., Walker, B. R., & Andrew, R. (2019) · Endocrinology · doi:10.1210/en.2019-00236 · Cited by 7
“mRNA transcript abundances were quantified by real-time PCR as previously described and with prim e s and probes as detailed in (4,17,18).”
MethodSelf-citationBuurstede, J. C., Paul, S. N., Bosscher, K. D., Meijer, O. C., & Kroon, J. (2022) · The FASEB Journal · doi:10.1096/fj.202101313r · Cited by 6
Feature, Function, and Information of Drug Transporter–Related Databases
Yin, J., Li, F., Li, Z., Yu, L., Zhu, F., & Zeng, S. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000419 · Cited by 5
“, 2015), (2) tissue-differential distributions (Nixon et al., 2016) and (3) disease-dependent abundances (Evers et al.”
BackgroundInfluentialDenham, S. G., Just, G., Kyle, C. J., Richardson, J., Lee, P. J., Simpson, J., Gifford, R. M., Andrew, R., Reynolds, R. M., & Homer, N. Z. M. (2020) · Preprints.org · doi:10.20944/preprints202011.0551.v1 · Cited by 5
“While cortisol is the main glucocorticoid in humans, measurement of corticosterone is becoming more relevant, showing increases in 17-hydroxylase deficiencies with evidence of potential benefit as a treatment in glucocorticoid deficiency [17].”
BackgroundSelf-citationLiu, W., Cao, H., Kimari, M., Maronitis, G., Williams, M. J., & Schiöth, H. B. (2021) · Membranes · doi:10.3390/membranes11060432 · Cited by 4
“The evolutionarily conserved MRP family member multidrug resistance protein 1 (MRP1) is widely expressed in metabolic and excretory tissues, including lung, kidney, intestines, and adipose [5,6].”
BackgroundGlucocorticoids associate with cardiometabolic risk factors in black South Africans
Dlamini, S. N., Lombard, Z., Micklesfield, L. K., Crowther, N. J., Norris, S. A., Snyman, T., Crawford, A. A., Walker, B. R., & Goedecke, J. H. (2021) · Endocrine Connections · doi:10.1530/ec-21-0195 · Cited by 4
Self-citationTaves, M. D., & Ashwell, J. D. (2020) · Nuclear Receptor Signaling · doi:10.1177/1550762919899643 · Cited by 5
“1,6,9,11 Finally, it allows detection of cell-specific variability in GC exposure, which could result from differences in anatomic context or expression of genes that alter GC access and activity.”
BackgroundKyle, C. J., Boyle, L. D., Nixon, M., Homer, N. Z. M., Simpson, J., Rutter, A., Ramage, L. E., Kelman, A., Freel, E. M., Andrew, R., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae144 · Cited by 4
Self-citationDiagnosis and Management of Adrenal Insufficiency
He, X., Findling, J. W., & Auchus, R. J. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_9 · Cited by 6
Steroid hormone signaling: What we can learn from insect models
Okamoto, N., Fujinaga, D., & Yamanaka, N. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2022.12.006 · Cited by 3
Circadian clocks in human cerebral organoidsPreprint
Rzechorzek, N. M., Sutcliffe, M. A., Mihut, A., Baranes, K., Karam, N., Sanchez, D. J. L.-D., Peak‐Chew, S., Zeng, A., Poulin, N. D., Seinkmane, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.20.580978 · Cited by 4
ATP-binding cassette family C member 1 constrains metabolic responses to high-fat diet in male mice
Villalobos, E., Miguelez-Crespo, A., Morgan, R., Ivatt, L., Paul, M. A., Simpson, J., Homer, N. Z. M., Kurian, D., Aguilar, J., Kline, R., et al. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0024 · Cited by 3
“A limitation of our studies is that we focused on subcutaneous WAT, in line with previous work demonstrating a role for ABCC1 in modulating exogenous glucocorticoid levels (Nixon et al. 2016).”
InfluentialSelf-citationJackwerth, M., Mairinger, S., Rausch, I., Weber, M., Jorda, A., Nics, L., Langsteger, W., Zeitlinger, M. A., Hacker, M., & Langer, O. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07121-5 · Cited by 2
Mapping endocrine networks by stable isotope tracing
Andrew, R., & Stimson, R. H. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100381 · Cited by 1
Self-citationParadigm shift for ACTH suppression
Holmes, D. I. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.155
Hypothalamic pituitary adrenal axis dysregulation in obese pregnancy
Stirrat, L. (2018) · ERA
Melvin, A., Chantzichristos, D., Kyle, C. J., Mackenzie, S. D., Br, W., Johannsson, G., Stimson, R. H., & O’Rahilly, S. (2020) · Yearbook of pediatric endocrinology · doi:10.1530/ey.17.8.16
Self-citationChernukha, I. M., Kotenkova, E., & Fedulova, L. (2023) · Foods and raw materials · doi:10.21603/2308-4057-2024-2-609
A review on Congenital Adrenal Hyperplasia andits management
Toms, C., Fathima, B., Neethu, R., & Reji, A. (2024) · International Journal of Advanced Research in Biological Sciences (IJARBS) · doi:10.22192/ijarbs.2024.11.06.002 · Cited by 1
Rapid turnover of corticosterone in humans
Nixon, M., Mackenzie, S. D., Devine, K., Kyle, C. J., Ostojic, A., Upreti, R., Homer, N. Z. M., Reynolds, R. M., Walker, B. R., Walker, B. R., et al. (2026) · European Journal of Endocrinology · doi:10.64898/2026.04.27.720824
Self-citationVanoye–Carlo, A., Parra-Hernández, S., Rodríguez-Cano, A. M., Perichart‐Perera, O., Tolentino‐Dolores, M. C., Cerbón, M. A., Pérez-González, O. A., & Nava-Salazar, S. (2026) · Metabolites · doi:10.3390/metabo16100734
“Previous studies reported that ABCC1 preferentially transports corticosterone and could affect the availability of glucocorticoids within tissues like adipose tissue [40–42].”
Metadata
- Authors
- Nixon, M., Mackenzie, S. D., Taylor, A. I., Homer, N. Z. M., Livingstone, D. E., Mouras, R., Morgan, R. A., Mole, D. J., Stimson, R. H., Reynolds, R. M., Elfick, A. P. D., Andrew, R., & Walker, B. R.
- Affiliations
- British Heart Foundation Centre for Cardiovascular Science (GB)
- The Queen's Medical Research Institute (GB)
- University of Edinburgh (GB)
- Centre for Inflammation Research (GB)
- Corresponding author
- Nixon, Mark
- Mackenzie, Scott D.
- Taylor, Ashley I.
- Walker, Brian R.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2016-08-17
- Volume
- 8
- Issue
- 352
- Pages
- 352ra109-352ra109
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2510336674
- Cited by
- 59
- References
- 44
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 9 · 2021: 7 · 2020: 6 · 2019: 9 · 2018: 4 · 2017: 4 · 2016: 1
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- British Heart Foundation
- Wellcome Trust
- Medical Research Council
- Engineering and Physical Sciences Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- MRP1, corticosterone, cortisol, P-glycoprotein, ABC transporters, glucocorticoid replacement therapy, congenital adrenal hyperplasia, Addison's disease, adipose tissue, probenecid, obesity, ACTH suppression, ACTH
- MeSH terms
- Addison Disease, Adipose Tissue, Adrenal Hyperplasia, Congenital, Adrenocorticotropic Hormone, Animals, Biological Transport, Active, Brain, Cells, Cultured, Corticosterone, Glucocorticoids, Humans, Hydrocortisone, Male, Mice, Inbred C57BL, Obesity, Organ Specificity, RNA, Messenger, Mice, Knockout, ATP-Binding Cassette, Sub-Family C Proteins, Mice, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.